“Toxicity and Safety of Induction Chemotherapy in Locally Advanced Oropharynx, Hypopharynx and Larynx: Non-Randomized Study Comparing DCF and Immunochemotherapy (ICT) with PF-Pembrolizumab”, Вопр. онкол., vol. 70, no. 6, pp. 1096–1105, Jan. 2025, doi: 10.37469/0507-3758-2024-70-6-1096-1105.